Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Total anomalous pulmonary venous connection (TAPVC) is a complex congenital heart disease,
requiring surgical repair. Pulmonary venous obstruction (PVO) is the major complication, with
limited effective reinterventions and poor outcomes. This trial aims at investigating that
postoperative anticoagulant management reduce the incidence of PVO.